David M. Knott Jr’s Ibere Pharmaceuticals IBER Stock Holding History

David M. Knott Jr’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,000	Closed	-$363K	–	180
2022 Q4	$363K	Hold	36,000	–	–	0.14%	65
2022 Q3	$357K	Hold	36,000	–	–	0.15%	76
2022 Q2	$353K	Hold	36,000	–	–	0.15%	74
2022 Q1	$353K	Hold	36,000	–	–	0.11%	86
2021 Q4	$348K	Buy	+36,000	New	+$350K	0.12%	78

David M. Knott Jr's IBER Position: Q1 2023 in Review

David M. Knott Jr sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 36,000 shares — an estimated $363K sold.

David M. Knott Jr first reported a position in IBER in Q4 2021 and held it in 5 quarters. The position peaked at $363K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

David M. Knott Jr reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
David M. Knott Jr sold 36,000 Ibere Pharmaceuticals shares in Q1 2023, an estimated $363K.
David M. Knott Jr first reported a position in Ibere Pharmaceuticals in Q4 2021 and held it in 5 quarters.
David M. Knott Jr's Ibere Pharmaceuticals position peaked at $363K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on David M. Knott Jr's 13F filing for Q1 2023, filed 11 May 2023.